Ending the Diagnostic Odyssey Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Jun 10, 2021)
Ending the Diagnostic Odyssey Act of 2021
This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.
Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.
The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.
What just happenedJun 10, 2021
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4046-4047)
Who’s behind it
- Introduced in SenateJun 10, 2021
- Jun 10, 2021IntroReferral
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4046-4047)
Finance Committee - Jun 10, 2021IntroReferral10000
Introduced in Senate